Aloracetam

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Aloracetam
Aloracetam.svg
Systematic (IUPAC) name
N-[2-(3-Formyl-2,5-dimethylpyrrol-1-yl)ethyl]acetamide
Legal status
Legal status
  • US: Not FDA approved; Unscheduled
Identifiers
CAS Number 119610-26-3 YesY
ATC code none
PubChem CID 178134
ChemSpider 155069 YesY
UNII U0RKZ75D0T YesY
ChEMBL CHEMBL2104637
Chemical data
Formula C11H16N2O2
Molar mass 208.257 g/mol
  (verify)

Aloracetam (INN) is a drug described as a nootropic which is closely related to, but technically not of (as it lacks a pyrrolidone ring), the racetam family of compounds.[1][2][3] It was studied by Aventis for the treatment of Alzheimer's disease,[4] but was never marketed.

See also[edit]

References[edit]

  1. ^ "The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" (PDF). World Health Organization. 2011. Retrieved 22 May 2015. 
  2. ^ Charles F. George (7 July 1998). Drug Therapy in Old Age. Wiley. ISBN 978-0-471-94149-1. 
  3. ^ C.R. Ganellin; David J. Triggle (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 615–. ISBN 978-0-412-46630-4. 
  4. ^ Fischer F, Matthisson M, Herrling P. List of Drugs in Development for Neurodegenerative Diseases. Neurodegenerative Diseases 2004;1:50–70.